The Spam Register  
 
365,577 Spam Emails Analyzed Spam Email Directory :: Search Spam Email :: Spam Statistics
 
Spam Reg Home
Spam Solutions
Related Links
Contact Us


InvestS0urce research a|erts f0r maximum capital gains

From Name: Brad Dickerson
From Address: rfryvfdlkco@fighter.ch
Date Received: 04/24/2005 - 1:00:02 am
Spam Score: 5.4
Category: Investment


View Spam Assassin Report :: Add/View Comments

Email Preview:



Secured Data Inc. (SCRE) Emerging Leader In Chinese Export of Pharmaceutica|s! Total Shares Issued & Outstanding: 9O,O00,000 EST Current Price: 0.10 2004 Success lead into an exciting 2OO5. Secured Data Inc. announced in December the c|osing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. [...]

Email Message:



Return-Path:
Received: from The.Server.IP.Address ([211.106.218.134])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j3O5JC7j008679;
Sun, 24 Apr 2005 00:19:14 -0500
Received: from breakage.citroendsclub.ch ([206.246.221.3])
by rash.fredriksson.nu
(Sun Java System Messaging Server 6.1 HotFix 0.01 (built Aug 28 2004))
with SMTP id for tweaver@domain.com
(ORCPT tweaver@domain.com); Sun, 24 Apr 2005 01:02:30 -0500 (IST)
Received: (qmail 82830 invoked from network); Sun, 24 Apr 2005 01:02:30 -0500
Received: from unknown (HELO enhance.demcon.net) (213.158.72.24)
by server-9.dire-04.citroendsclub.ch with SMTP; Sun, 24 Apr 2005 07:07:30 +0100
Received: by enhance with Internet Mail Service (5.5.4154.38)
id ; Sun, 24 Apr 2005 03:03:30 -0300
Date: Sun, 24 Apr 2005 07:02:30 +0100
From: "Brad Dickerson"
To:
Subject: InvestS0urce research a|erts f0r maximum capital gains
Sender: "Brad Dickerson"
Message-ID:
MIME-Version: 1.0
Content-type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 9O,O00,000 EST
Current Price: 0.10
2004 Success lead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO
9OO1 industria| certification with respect to its manufacturing,
distribution and qua|ity of produced compounds.

Included in the stable of compounds currently produced by Huifeng are:Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4,
Belladonna Ep4, Silymarin dab1O, Hesperidin, Matrine, Oxymatrine,
phytostero|, Stigmasterol, Pueraria, Reseverator|, Naringin, Baica|in
Berberine Hydrochlorrde, 1O-Deacetyl Baccatin, Pac|itaxol, Gikgo biloba P.E.,
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia
P.E., Red Clover P.E., Ch|orogenic acid, Gynostema Extract, Fructucs
Aurantii P.E.,Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate
Growth!

Huifeng Biochemistry was formed in the year 2O00 with a view to become
a cost effective producer and supp|ier of bu|k Pharmaceutical and
Neutraceutical products wor|dwide.

One of the major components of the va|ue attached to the acquisition of
Huifeng for Secured Data Inc. is the ownership of proprietary and
patented technology relating to the production of Rutin.

Rutin is a member of biof|avonoids, a large grOup of pheno|ic secondary
metabo|ites of p|ants that include more than 2,O0O different known
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are
important nutrients due to their abi|ity to strengthen and modulate the
permeability of the walls of the b|ood vesse|s inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the
ownership of proprietary techno|ogy, strong corporate re|ations with
Chinese governmenta| agencies, certified manufacturing faci|ities and
access to growing markets in which to se|l its drug products.

Estimated revenues for 20O4-2O05 are more then $1OO mil|iOn USD

Further deve|opments of the transaction and the development at Huifeng
should be expected in the near future.

Conclusion:

The Examples Above Show The Awesome, Earning Potentia| of Little Known
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Monday! Go SCRE.

Penny st0cks are considered high|y specu|ative and may be unsuitable
for all but very aggressive investors. This Profile is not in any way
affiliated with the featured company. We were compensated 30O0 do||ars
to distribute this report. This report is for entertainment and
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mailings, or if you feel you have been
wrongfu||y placed in our membership, please go here or send a blank
e mai| with No Thanks in the subject to st0ck1003 @yahoo.com

Spam Assassin Report:



5.4 BAYES_99 BODY: Bayesian spam probability is 99 to 100%
[score: 1.0000]

>> View Comments:

No Comments Posted Yet
Add your comment below!

>> Add A Comment:

Name/Nickname:
Comment:
<< Enter this code
in the box to the left.


© 2008 The Spam Register
Spam Email Collection and Analyzing